Vtvt stock price target

The 2 analysts offering 12-month price forecasts for vTv Therapeutics Inc The current consensus among 2 polled investment analysts is to Buy stock in vTv  Their average twelve-month price target is $7.00, suggesting that the stock has a possible upside of 284.62%. The high price target for VTVT is $8.00 and the  2 Wall Street analysts have issued twelve-month target prices for vTv Therapeutics' shares. Their forecasts range from $6.00 to $8.00. On average, they expect vTv 

In depth view into VTVT (vTv Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. vTv Therapeutics (NASDAQ: VTVT) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers  Real-time trade and investing ideas on vTv Therapeutics VTVT from the largest community of traders and investors. Based on 2 analysts offering recommendations.

VTVT: vTv Therapeutics Inc. - Price & EPS Surprise - Zacks.com

VTVT Stock Price | vTv Therapeutics Inc. Cl A Stock Quote ... VTVT | Complete vTv Therapeutics Inc. Cl A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. VTVT - vTv Therapeutics Inc Stock quote - CNNMoney.com Find real-time VTVT - vTv Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. VTVT - vTv Therapeutics Inc Stock quote - CNNMoney.com Markets VTVT Stock Quote - vTv Therapeutics Inc. Class A Common ... Stock quote for vTv Therapeutics Inc. Class A Common Stock Common Stock (VTVT) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. VTVT Stock Forecast - Buy or Sell? vTv Therapeutics Inc.

vTv Therapeutics (VTVT) Stock Price and Discussion (March ...

Do Analysts Recommend You Should Buy vTv Therapeutics Inc ... Mar 02, 2020 · Additionally, VTVT shares got another “Buy” rating from ROTH Capital, setting a target price of $17 on the company’s shares, according to the report published in March 8th, 2018. On February 8th, 2018, Northland Capital Initiated an Outperform rating and increased its price target to $28. Vtv Therapeutics Inc. - VTVT - Stock Price Today - Zacks View vTv Therapeutics Inc. VTVT investment & stock information. Get the latest vTv Therapeutics Inc. VTVT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Nov 07, 2019 · vTv Therapeutics Inc. Cl A analyst estimates by MarketWatch. View VTVT revenue estimates and earnings estimates, as well as analyst recommendations.

VTVT Stock | VTV THERAPEUTICS Stock Price Today | Markets ... VTVT: Get the latest vTv Therapeutics stock price and detailed information including VTVT news, historical charts and realtime prices. VTVT Stock Price and Chart — NASDAQ:VTVT — TradingView — … TradingView India. View live VTV THERAPEUTICS INC chart to track its stock's price action. Find market predictions, VTVT financials and market news. VTVT vTv Therapeutics Inc. Stock Quote Stock screener for investors and traders, financial visualizations. VTVT: vTv Therapeutics Inc. - Price & EPS Surprise - Zacks.com

VTVT: vTv Therapeutics Inc. price and EPS surprise. Get the latest price and EPS surprise information from Zacks Investment Research.

VTVT updated stock price target summary. Dow Jones, a News Corp company. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. VTVT | vTv Therapeutics Inc. Cl A Stock Price & News - WSJ View the latest vTv Therapeutics Inc. Cl A (VTVT) stock price, news, historical charts, analyst ratings and financial information from WSJ. 12 Healthcare Stocks Moving In Monday's Pre-Market Session Feb 10, 2020 · The most recent rating by Mizuho, on February 06, is at Neutral, with a price target of $148.00. • ReWalk Robotics, Inc. (NASDAQ: RWLK ) shares declined 4.7% … VTVT Stock Quote - vTv Therapeutics, Inc. Stock Price Today

vTv Therapeutics (NASDAQ: VTVT) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers